Axon Enterprise (AXON)
NASDAQIndustrialsAerospace & DefenseSnapshot 2026-07-07
$640.46+2.91%
Close 2026-07-07 · 1-day change
Reading AXON? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track AXON free→NASDAQIndustrialsAerospace & DefenseSnapshot 2026-07-07
Reading AXON? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track AXON free→Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Aerospace & Defense is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue is growing steadily — about 34% over the past year.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 32%, softest on returns on capital.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look high — the market is pricing in about 71% growth a year, above the roughly 36% analysts expect, leaving little room for error.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 60% in its worst 12-month stretch.
View RiskAxon Enterprise's growth depends on AI and counter-drone demand to justify its price. Revenue grew 34% year over year in Q1 2026, and the last quarter beat expectations. It trades at 17× price-to-sales versus a peer median of 3.5×. The market is pricing in more growth than we forecast, making expectations look full. If Axon cuts guidance on the next call, it could negatively impact the stock. Peer multiples imply a price about 70% below where it trades. This read is provisional.
Trailing returns as of 2026-07-07. AXON is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 20 analysts currently covering AXON (as of Jul 2026).
Based on 6 Wall Street analysts offering 12-month price targets for AXON in the last 4 months.
A consensus fair price across 7 valuation methods, at three horizons. Current price $640.46. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Aerospace & Defense — fair value, gap to price, and forward P/E.
Strong Q1 growth supports revenue growth objective.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-07. EPS is implied from price ÷ P/E. Not investment advice.
Current $640.46
The last 12 months of price, then the range of analyst 12-month targets from today’s $640.46.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
AI and counter-drone demand align with growth targets.
Higher guidance indicates confidence in revenue growth.